Speaker Archives - PHEN Summit

Andrew C. Peterson, MD

Sep 12, 2022

Urologist, Survivorship Care Surgeon

Duke University School of Medicine

Dr. Peterson received his medical degree from Dartmouth Medical School in 1995 and completed his urology residency at Madigan Army Medical Center in 2002. He subsequently completed an advanced fellowship in Reconstructive Urology at Duke University in 2003. He then returned to Madigan Army Medical Center where he served as the Chief of Reconstructive Urology and the director of the urology residency.

Dr. Peterson joined the faculty at Duke in 2010 and currently serves as the Vice Chief of Medical Operations, the Urology Residency Program Director and directs the “Reconstructive Urology and Genitourinary Cancer Survivorship Fellowship”.

His research interests include improving the care of cancer survivors and the prevention of genitourinary side effects from various medical, surgical and radiation therapies for cancer. His clinical interests include reconstructive urology and bladder dysfunction in men and women; urinary incontinence in men; reconstruction for urethral stricture and trauma; new bladder construction and urinary diversion; video urodynamic study with particular value to patients with bladder-emptying problems and bladder-outlet symptoms; care of prostate cancer survivors with respect to sexual function and urinary continence, and urethral stricture disease after treatment with surgery or radiation. He is specifically skilled in the multidisciplinary management of complex genitourinary problems including scar tissue (bladder neck contracture, ureteral stricture), fistulas, radiation cystitis, and voiding dysfunction often seen in survivors of genitourinary cancers. He offers advanced surgical care including urethroplasty, placement of the artificial urinary sphincter (AUS), penile prosthesis, male sling, repair of recto-urethral fistula, and ureteral reimplantation for stricture.

During his 23 years in the United States Army Dr. Peterson achieved the rank of Colonel retiring from the Army Reserves in 2014. He is a graduate of the Command and General Staff College, and has been awarded the Expert Field Medical Badge, the Meritorious Service Medal with 3 oak leaf clusters, and the Bronze Star. He currently serves on the review panel of multiple peer reviewed journals. He is an active member of the Society for Genitourinary Reconstructive Surgeons and the Society for Government Service Urologists as well as the American Urologic Association.

Return to Session Four

Jeremy Tonkin, MD

Sep 12, 2022

Associate Professor of Medicine in the Department of Surgery / Division of Urology

Howard University Hospital

Dr. Jeremy Tonkin is currently an Associate Professor of Medicine in the Department of Surgery/Division of Urology at Howard University in Washington D.C. A native of Kansas City, Dr. Tonkin graduated from the University of Missouri-Kansas City 6-year combined BA/MD program. He did his general surgery and urologic surgery training at the University of Oklahoma. He then completed at 2-year fellowship in reconstructive urology at Eastern Virginia Medical School in Norfolk, VA.

In addition to general urology, Dr. Tonkin’s practice has a special focus on reconstructive urology. This includes the treatment of erectile dysfunction, male incontinence, urethral stricture disease, Peyronie’s disease, fistula repair and cosmetic genital surgery. He also specializes in other aspects of men’s heath such as androgen replacement and BPH.

Return to Session

Heather H. Goltz, PhD, MSW

Sep 9, 2022

Interim Assistant Chair of Criminal Justice and Social Work & Professor

University of Houston-Downtown

Dr. Heather Honoré Goltz is an oncology social worker, health educator, and sex therapist with over 15 years of experience developing and implementing clinical and psychosocial interventions for patients, caregivers, and couples impacted by complex medical and behavioral health conditions. She has earned degrees in biology (BS, Northwestern State University), social work and curriculum/instruction (MSW and MEd, University of Houston), health education and public health (PhD and MPH-Epidemiology, Texas A&M University). She completed post-doctoral fellowships in health services research and urology from the Michael E. DeBakey VAMC and Baylor College of Medicine, respectively, prior to her course of study in the University of Michigan’s Sexual Health Certificate Program sex therapy track. Dr. Goltz is a long-term member of the American Association of Sexuality Educators, Counselors, and Therapists (AASECT), the Association of Oncology Social Work (AOSW), the American Public Health Association (APHA), and the National Association of Social Workers (NASW). She is the current Co-Chair of the Bladder Cancer Advocacy Network’s Survivorship Working Group and the current AOSW Education Director. Dr. Goltz has co-authored over 40 peer-reviewed articles and collaborated on $3 million in research grants funded by ACS, NIH, DOD, and VA, primarily focusing on genitourinary cancer survivorship, cancer disparities, and sexual health.

LinkedIn

Return to Session

Lola A. Fashoyin-Aje, MD, MPH

Sep 9, 2022

Medical Oncologist and Deputy Director in the Division of Oncology

Food and Drug Administration (FDA)

Lola A. Fashoyin-Aje, MD, MPH, is a medical oncologist and Deputy Division Director in the Division of Oncology 3 (DO3) in the Office of Oncologic Diseases (OOD) at the Food and Drug Administration (FDA).

Lola A. Fashoyin-Aje, MD, MPH, is a medical oncologist and Deputy Director in the Division of Oncology 3 (DO3) in the Office of Oncologic Diseases (OOD) at the Center for Drug Evaluation and Research- Food and Drug Administration (FDA). In this role, she provides scientific and policy guidance and oversight to multidisciplinary teams reviewing drugs and biologics under development for the treatment of solid tumor malignancies (gastrointestinal, cutaneous, and sarcoma). Dr. Fashoyin-Aje is also an Associate Director at the FDA Oncology Center of Excellence at the FDA, leading scientific and policy initiatives to address disparities and other regulatory science issues in oncology drug development. Prior to joining the FDA, Dr. Fashoyin-Aje completed her undergraduate and graduate training at Columbia University and Yale University, respectively, and received her M.D. degree from the University of Rochester School of Medicine and Dentistry. She completed her training in internal medicine and medical oncology at Johns Hopkins.

Return to Session Three

Won Kim, MD

Sep 9, 2022

Senior Medical Director

Janssen

Won Kim, MD, is a Senior Medical Director in Clinical Oncology at Janssen. He serves as the study responsible physician for multiple prostate cancer clinical trials. Before joining Janssen in November 2020, Won was a genitourinary medical oncologist at Kaiser Permanente, caring for patients with prostate, bladder, kidney, and testis cancer. He practiced in Oakland, California, serving an incredibly diverse patient population. One of his main research interests at Kaiser Permanente was the equitable implementation of genomic testing for patients with genitourinary cancers.

Won completed his internal medicine residency at Weill Cornell Medical College in New York City, and after serving as Chief Resident at Cornell, he completed his medical oncology fellowship training at the University of California, San Francisco (UCSF). He was then recruited to join the faculty at UCSF as an Assistant Professor in the Division of Hematology and Oncology, and was an active member in Prostate Cancer Program and the Cancer Immunotherapy Program at the UCSF Helen Diller Family Comprehensive Cancer Center. He received multiple peer-reviewed grants to support his work in patient-centered prostate cancer research, including from the Prostate Cancer Foundation, and served as principle investigator for multiple clinical trials, and is the author of numerous publications. He served as the clinical leader of the UCSF Kidney Cancer program and as a member of the National Comprehensive Cancer Network Kidney Cancer Guidelines Panel. During his time at UCSF, Won was the associate program director of the UCSF Hematology/Oncology Training Program, and led efforts to bring diversity, equity and inclusion into the training program’s recruitment strategy, and helped to establish a new Hematology/Oncology training program at Kaiser Permanente.

Return to Session Three

Elisabeth I. Heath, MD, FACP

Sep 7, 2022

Genitourinary Oncologist

Karmanos Cancer Institute

Elisabeth I. Heath, MD, FACP, serves as the Associate Center Director of Translational Sciences and leads the Genitourinary Oncology Multidisciplinary Team at the Karmanos Cancer Institute. She is the medical director of the Infusion Center and is director of prostate cancer research. She is an active clinical and scientific member of Karmanos and is professor of Oncology at Wayne State University School of Medicine. Dr. Heath has a distinguished career as a prostate cancer researcher, serving as the Patricia C. and E. Jan Hartmann Endowed Chair for Prostate Cancer Research. Her focus is in conducting clinical and translational research trials in genitourinary oncology with critical attention to the area of health disparity, particularly with regard to the poor accrual of minority

patients to prostate cancer clinical trials. She is the principal investigator of the Michigan Prostate SPORE as well as for a Department of Defense grant in the nationally-recognized Prostate Clinical Trials Cancer Consortium.

Dr. Heath is a member of the Prostate Cancer Foundation Research Awards Review Committees and Department of Defense prostate and kidney cancer study section. She has served as president for the KCI Medical Executive Committee, has served as member of the Executive Committee of the Faculty Senate at Wayne State University School of Medicine, and is currently on the board of directors of the state-sponsored Michigan Cancer Consortium.

Dr. Heath was honored with the inaugural Michigan Cancer Consortium Champion Award for 2016. In addition, Dr. Heath was also the recipient of the National Cancer Institute Clinical Investigator Team Leadership Award in 2010. She has also been awarded the Wayne State University School of Medicine College Teaching Award in 2007, 2011, 2015 and holds the Top Doc designation in Hour Magazine from 2010-2021. Dr. Heath served for 10 years as the Faculty Advisor for the Gold Humanism Honor Society and has been the recipient of the Leonard Tow 2009 Humanism in Medicine Award. She was the recipient of the Wayne State University School of Medicine Physician’s Golden Heart Award in 2011. Dr. Heath is a dedicated clinician-scientist, researcher, and teacher at Wayne State University School of Medicine.

She earned her medical degree from Thomas Jefferson University in Philadelphia, PA, completed her internal medicine residency at Georgetown University Hospital, Washington, DC, and completed her medical oncology fellowship at Johns Hopkins School of Medicine, Baltimore, MD.

Return to Session Three